Navigation Links
PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022
Date:5/14/2013

NEW YORK, May 14, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022
http://www.reportlinker.com/p01171153/PharmaPoint-Multiple-Sclerosis---China-Drug-Forecast-and-Market-Analysis-to-2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022

Summary

GlobalData has released its new Country report, "PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022". Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous system. With curative therapy still elusive, current disease management is dependent on life-long pharmacotherapy with disease-modifying therapies (DMT). The dominance of first-line injectable DMTs, including the interferon beta (IFNß) agents: Bayer's Betaseron/Betaferon (IFNß-1b), Biogen's Avonex (IFNß-1a) and Merck's Rebif (IFNß-1a), and Teva's Copaxone (glatiramer acetate), has been a salient feature of the MS therapeutics market. However, the competitive landscape is undergoing significant change with the emergence of oral therapies, several pipeline products with notable efficacies, and looming generics/biosimilars following the patent expiries of key branded products dur
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. PharmaPoint: Osteoporosis - US Drug Forecast and Market Analysis to 2022
2. PharmaPoint: Osteoporosis - India Drug Forecast and Market Analysis to 2022
3. In Relapsed/Refractory Multiple Myeloma, Thought Leaders Are Optimistic that the Combination of Carfilzomib, Lenalidomide and Dexamethasone Will Be the Most Efficacious Regimen
4. Hobart Group Holdings Marks 10th Anniversary With Multiple Milestones
5. Mapi Pharma Granted United States Patent Covering Glatiramer Depot for Multiple Sclerosis
6. For Pharma Companies, Launching Multiple Similar Products Can Be a "Good Problem" but Requires Smart Resourcing
7. Deploying an Effective Pay for Performance Bonus System that Works Across Multiple Industry Sectors
8. Aurigene Announces Transition of Multiple Programs to Clinical Development in its Collaboration Business
9. Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis
10. Surveyed U.S. Neurologists Would Prescribe Biogen Idecs Tecfidera to 20 Percent of Their Patients with Relapsing-Remitting Multiple Sclerosis (RR-MS)
11. Star Scientific, Inc. Issues Statement in Response to Two Plaintiffs Purported Class Action Law Suits and Multiple Press Releases Issued by Plaintiffs Law Firms Trolling for New Clients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... 1, 2014 Reportbuyer.com has added a ... Aesthetic Lasers and Energy Devices Market Outlook to ... Brazil Aesthetic Lasers and Energy Devices ... GlobalData,s new report, "Brazil Aesthetic Lasers ... key market data on the Brazil Aesthetic Lasers ...
(Date:9/1/2014)... Sept. 1, 2014 Reportbuyer.com has ... Rigid Transparent Plastics: Global Markets Outside ... INTRODUCTION This chapter provides ... the study goals and objectives, reasons for ... information sources and analyst credentials, and related ...
(Date:8/30/2014)... , Aug. 30, 2014   Royal Philips  (NYSE: ... Affiniti, a new ultrasound system designed to enable ... of increasing patient volumes and cost pressures. Making its ... in Barcelona this week, ... more patients with fewer resources deliver high quality patient ...
Breaking Medicine Technology:Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 2Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 3Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 4Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 5Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 6Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 7Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 8Brazil Aesthetic Lasers and Energy Devices Market Outlook to 2020 9Rigid Transparent Plastics: Global Markets Outside North America 2Rigid Transparent Plastics: Global Markets Outside North America 3Rigid Transparent Plastics: Global Markets Outside North America 4Rigid Transparent Plastics: Global Markets Outside North America 5Rigid Transparent Plastics: Global Markets Outside North America 6Rigid Transparent Plastics: Global Markets Outside North America 7Rigid Transparent Plastics: Global Markets Outside North America 8Rigid Transparent Plastics: Global Markets Outside North America 9Rigid Transparent Plastics: Global Markets Outside North America 10Rigid Transparent Plastics: Global Markets Outside North America 11Rigid Transparent Plastics: Global Markets Outside North America 12Rigid Transparent Plastics: Global Markets Outside North America 13Rigid Transparent Plastics: Global Markets Outside North America 14Rigid Transparent Plastics: Global Markets Outside North America 15Rigid Transparent Plastics: Global Markets Outside North America 16Rigid Transparent Plastics: Global Markets Outside North America 17Rigid Transparent Plastics: Global Markets Outside North America 18Rigid Transparent Plastics: Global Markets Outside North America 19Rigid Transparent Plastics: Global Markets Outside North America 20Rigid Transparent Plastics: Global Markets Outside North America 21Rigid Transparent Plastics: Global Markets Outside North America 22Rigid Transparent Plastics: Global Markets Outside North America 23Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4
... CITY, Calif., Feb. 23, 2011 Abaxis, Inc. (Nasdaq: ... analysis systems, announced today that Clint Severson, chairman and chief ... Conference on Thursday, March 3, 2011 at 10:00 a.m. ET. ... Hotel in New York City. A live webcast ...
... Foundation and Vertex Pharmaceuticals announced today that VX-770, an oral ... cystic fibrosis, showed promising results in a Phase 3 clinical ... patients age 12 and up who carry at least one ... 161 patients who received at least one dose of VX-770 ...
Cached Medicine Technology:Abaxis, Inc. to Present at RBC Capital Markets' Healthcare Conference 2Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation 2Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation 3
(Date:9/2/2014)... (PRWEB) September 02, 2014 Headaches, both chronic ... from going to work, enjoying family and friends, sleeping and ... is the single leading cause of disability worldwide. The ... carry serious risks. , Most of these cases of headache ... to treat them with prescriptions will not detect and fix ...
(Date:9/2/2014)... BESLER Consulting, a leading provider of Medicare ... to announce that it has released a special report ... 2015 Hospital Inpatient Prospective Payment System (IPPS) final rule ... Services. , “Hospitals are facing decreased Medicare reimbursements in ... BESLER’s President and Chief Executive Officer. “We are happy ...
(Date:9/2/2014)... 2014 With thoughts of getting the ... minds of many Washingtonians, it’s easy to forget that ... office managers to be booking their organizations’ holiday parties ... Washington, DC, area locations are preparing for the holiday ... for holiday parties, the space appears to be going ...
(Date:9/2/2014)... York (PRWEB) September 02, 2014 “Is ... is the question that millions of people ask. Diagnosing ... care providers, patients and their families or treatment partners. ... due to its distinct similarities to other skin conditions ... bed bug bites, eczema, varicella and many others. ...
(Date:9/2/2014)... OH (PRWEB) September 02, 2014 Request A ... testing, is offering a 10% discount on all drug testing ... savings, customers just need to use promo code DRUG10 when placing ... testing on urine, blood and hair. Drug testing is typically ... drugs. Some of the most popular panels include the ...
Breaking Medicine News(10 mins):Health News:Physical Therapists in Houston Learn Pain Relief Techniques 2Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 2Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 3Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 4Health News:Fall in Washington, DC, Is When a Meeting Planner’s Mind Turns to … the Winter Holidays? 5Health News:New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout 2Health News:New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout 3Health News:New Breakthrough Formula - Dr. Scabies® : The New Industry Standard Treatment for Scabies to Fight the Scabies Breakout 4Health News:Request A Test Offers 10% Off Drug Testing in September 2014 2Health News:Request A Test Offers 10% Off Drug Testing in September 2014 3
... Information Technology to Meet Today,s Healthcare Challenges, ... Quantum Group,Inc. (AMEX: QGP, QGP.WSA, QGP.WSB) ... CEO, Noel J. Guillama has been asked ... Corporation,s 7th Annual Life,Science Conference, "Leveraging Information ...
... Limited-edition CD at Participating Giant Stores on Saturday, May 3 and ... ... ,Everyone,s a winner when you stop into participating Giant stores,throughout the Washington ... Game(R) Scoop Day event., This year, EDY,S Grand Ice Cream hopes ...
... 22 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ... presentations given at the Company,s Investor and,Analyst Day on ... Phase 1 and Phase 2 results of the Company,s ... design for AZ-004 (Staccato(R),loxapine), and discuss the role that ...
... Upholds Rights of 10,000 University of California RNs to ... Bargain Over Improved Patient ... victory for public,employees, the California Nurses Association/National Nurses Organizing,Committee today ... of California registered nurses it represents to strike, and to,bargain ...
... in light of a,recent study released by the ... is National STD Awareness Month, Congresswoman Stephanie Tubbs,Jones, ... a bi-partisan,resolution urging the House of Representatives to ... screening and treatment of,sexually transmitted diseases (STD)., ...
... warning to pregnant women that drug use can affect ... -- A combination of THC, the main psychoactive ingredient ... widespread nerve cell death in the brains of young ... Humboldt University, Berlin, administered THC, a synthetic form of ...
Cached Medicine News:Health News:The Quantum Group CEO to Deliver Keynote Address at EDC Life Science Conference 2Health News:The Quantum Group CEO to Deliver Keynote Address at EDC Life Science Conference 3Health News:EDY'S(R) SLOW CHURNED(R) and Giant Food Markets Announce Scoop Day With Sweet Deals to Support the Fight Against Childhood Cancer 2Health News:Alexza to Webcast Investor and Analyst Day Presentations 2Health News:Alexza to Webcast Investor and Analyst Day Presentations 3Health News:CNA/NNOC Wins Key Legal Decision Protecting Right of Public Employees to Strike 2Health News:Tubbs Jones Introduces Resolution Encouraging STD Prevention 2Health News:Pot Plus Alcohol Kills Young Rats' Brain Cells 2
Near point card/newspaper 8 to 48 point type 5 1/2" X 8"....
Rosenbaum card fits in the pocket (3.5 by 6.5") and shows point, Jaeger and distance equivalents from 20/800 to 20/20. Uses numbers, directional Es and XO patterns. For use at 14" (35 mm). Includes f...
Standard reading test. "Value, care for..."...
Standard reading test. "Clearing weather..."...
Medicine Products: